Results 1 to 10 of about 757,150 (425)
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation [PDF]
Blood, 1978 Production of tissue mast cells was evaluated in genetically anemic mice of W/Wv genotype and was found to be abnormal. In the skin of adult W/Wv mice the number of mast cells/cm was less than 1% of the number observed in the congeneic +/+ mice.
Yukihiko Kitamura, S Go, K. Hatanaka
openalex +2 more sources
Bone marrow transplantation [PDF]
, 2008 Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenFor the last few decades there has been a major increase in the number of allogeneic bone marrow transplantations and every year several thousand transplants ...
Sigrún E.Þ. Reykdal
core +3 more sources
CA: A Cancer Journal for Clinicians, 1986 The current status of bone marrow transplantation is reviewed. The diseases that are treatable with marrow transplantation, the basic transplant procedure, and the potential complications of marrow transplantation are discussed in detail. The future application of marrow transplantation to additional disease processes is considered.
C B, Thompson, E D, Thomas
openaire +4 more sources
The Differentiation Balance of Bone Marrow Mesenchymal Stem Cells Is Crucial to Hematopoiesis. [PDF]
, 2018 Bone marrow mesenchymal stem cells (BMSCs), the important component and regulator of bone marrow microenvironment, give rise to hematopoietic-supporting stromal cells and form hematopoietic niches for hematopoietic stem cells (HSCs).
Li, Shengwen Calvin +6 more
core +7 more sources
Survival Prediction of Children Undergoing Hematopoietic Stem Cell Transplantation Using Different Machine Learning Classifiers by Performing Chi-squared Test and Hyper-parameter Optimization: A Retrospective Analysis [PDF]
, 2022 Bone Marrow Transplant, a gradational rescue for a wide range of disorders emanating from the bone marrow, is an efficacious surgical treatment. Several risk factors, such as post-transplant illnesses, new malignancies, and even organ damage, can impair long-term survival. Therefore, technologies like Machine Learning are deployed for investigating the
arxiv +1 more source
BMC Cancer, 2019 Following publication of the original article [1], the authors reported that the incorrect Fig. 2A was published in the article. The recovery times required to achieve a normal neutrophil count was omitted. The corrected Fig.
Mengqi Jin +9 more
doaj +1 more source
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
Thrombosis Journal, 2022 Background Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but devastating adverse event following adenoviral vector-based vaccinations for COVID-19, resulting in thrombosis, especially of the cerebral and splanchnic vasculature. Despite the
Christy V. John +5 more
doaj +1 more source
Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons [PDF]
, 1997 Background. Prior to organ harvesting, an attempt was made to modulate the donor's immune responses against prospective xenogeneic recipients by infusion of 'recipient-type' bone marrow. Methods.
Fontes, P +7 more
core +1 more source
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. [PDF]
, 2000 BACKGROUND: Donor chimerism (the presence of donor cells of bone marrow origin) is present for years after transplantation in recipients of solid organs. In lung recipients, chimerism is associated with a lower incidence of chronic rejection.
Fung, JJ +8 more
core +1 more source
BMJ, 2002 Bone marrow, or haematopoietic stem cell, transplants were originally developed to allow the use of very high dose treatments for malignancies such as leukaemia. Their use was based on the ideathat the high dose treatment might overcome inherent resistance of the malignancy to chemotherapy or radiotherapy. Transplants of stem cells from either the same
Johnson, Peter W. M., Orchard, Kim
openaire +4 more sources